Orgenesis Inc.

ORGS

Orgenesis Inc.

ORGS

Insider Sentiment (TTM):

Last Purchase:2024-06-24Last Sale:2024-06-24Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-03-31Institutional Shares Owned:50,623Shares Outstanding:4,210,839Institutional Ownership Pct.:1.20%

Earnings Market Reaction:

Filing Date:2026-03-26Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	0	0	0	0	1	0	0	3	5	3	2	1
Restricted Cash Current	1	1	1	0	1	1	1	1	1	1	0	0
Accounts Receivable Net Current	0	0	0	0	0	0	0	21	36	24	19	17
Due From Related Parties Current	-	-	-	-	-	-	-	-	3	-	-	-
Other Receivables Net Current	-	-	-	-	-	-	-	3	-	-	-	-
Prepaid Expense And Other Assets Current	0	1	1	1	2	4	4	5	1	1	1	1
Notes And Loans Receivable Net Current	-	-	-	-	-	-	-	-	-	-	-	1
Inventory Net	-	-	-	0	0	0	0	0	0	0	0	0
Assets Current	1	3	2	2	4	6	7	30	46	32	25	24
Assets Noncurrent
Investments	-	-	-	-	-	-	-	-	-	2	2	2
Deposits Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	-	-	-	0	0	0	0	0	0	-	-	-
Property Plant And Equipment Net	1	15	16	16	1	2	1	22	23	17	14	11
Intangible Assets Net Excluding Goodwill	-	9	9	9	7	8	8	9	10	11	11	12
Operating Lease Right Of Use Asset	-	2	2	2	0	0	0	3	2	1	1	1
Goodwill	-	1	1	1	1	1	1	8	8	8	8	8
Deferred Income Tax Assets Net	-	-	-	-	-	-	-	0	0	-	-	-
Other Assets Noncurrent	-	0	0	0	0	1	1	1	1	1	1	1
Assets Noncurrent	1	27	28	29	10	12	12	44	45	39	37	35
Assets	1	30	31	31	15	18	18	74	91	71	63	59
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	-	-	-	-	-	-	-	4	4	5	5	7
Bank Overdrafts	0	-	-	-	-	-	-	-	-	-	-	-
Accrued Liabilities Current	2	3	3	4	2	2	2	3	3	-	-	-
Accrued Income Taxes Current	1	1	1	1	1	1	1	0	0	0	0	0
Employee Related Liabilities Current	2	2	2	2	1	1	1	2	2	2	2	2
Contract With Customer Liability Current	-	-	-	-	-	-	-	0	0	0	0	0
Loans Payable Current	6	-	-	-	1	-	-	-	-	-	-	-
Finance Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	1	1	0	0	0
Other Liabilities Current	-	-	-	-	-	-	-	2	5	22	-	-
Convertible Debt Current	-	-	-	-	-	3	-	-	-	-	6	3
Short Term Borrowings	6	5	1	1	1	0	-	-	-	-	-	-
Convertible Notes Payable Current	2	2	2	2	3	-	2	-	5	-	-	-
Liabilities Current	27	36	32	29	16	14	13	14	16	34	16	15
Liabilities Noncurrent
Operating Lease Liability Noncurrent	1	2	1	1	0	0	0	2	2	1	0	0
Long Term Loans Payable	3	3	3	3	-	-	-	-	-	-	-	-
Convertible Debt Noncurrent	6	5	5	20	19	18	18	17	13	5	14	8
Pension And Other Postretirement And Postemploymen…	-	0	0	0	-	-	-	0	0	0	0	0
Finance Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities Noncurrent	2	2	0	0	0	0	0	0	0	0	0	0
Liabilities Noncurrent	12	18	15	29	19	19	18	20	16	6	15	8
Liabilities	39	54	46	58	36	33	31	34	32	40	31	24
Stockholders Equity Inclu…
Redeemable Noncontrolling Interest Equity Carrying…	-	-	-	-	-	-	-	30	30	-	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	188	182	181	160	157	156	155	151	150	149	147	146
Accumulated Other Comprehensive Income Loss Net Of…	0	-0	0	0	0	0	0	-0	-0	-1	-0	0
Treasury Stock Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-225	-204	-195	-186	-177	-170	-166	-141	-121	-117	-116	-110
Stockholders Equity	-38	-24	-16	-28	-21	-15	-13	10	28	30	32	35
Minority Interest	-0	-0	-0	0	-	-	-	1	2	0	0	0
Liabilities And Stockholders Equity	1	30	31	31	15	18	18	74	91	71	63	59
Accounts Receivable Related Parties Current	-	-	-	-	-	-	-	-	-	2	2	2
Allowance For Doubtful Accounts Receivable	-	-	-	-	-	-	-	9	-	-	-	-
Allowance For Doubtful Accounts Receivable Current	14	14	29	30	0	0	0	-	0	-	-	-
Common Stock Par Or Stated Value Per Share	-	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	15	15	146	146	15	146	146	146	146	146	146	146
Common Stock Shares Issued	5	5	5	3	3	3	3	3	3	3	3	3
Shares Outstanding	5	5	5	3	3	3	3	3	3	3	2	2
Treasury Stock Shares	-	-	-	-	-	-	-	-	0	0	0	0
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2024	5.36%	34.11%	32.29%	-14.84%	-32.62%	-84.74%	-8.00%	68.00%	15.20%	-68.00%	-99.40%	-1.00%
2023	8.76%	28.11%	-2.30%	-41.18%	-37.12%	-6.85%	-17.57%	-21.92%	-44.29%	16.07%	-5.94%	35.88%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Liquidity Ratios
Current Ratio	0.03	0.07	0.07	0.07	0.25	0.42	0.51	2.18	2.91	0.93	1.57	1.57
Quick Ratio	0.03	0.04	0.04	0.03	0.12	0.13	0.17	1.80	2.84	0.90	1.51	1.47
Working Capital	-26.16M	-33.53M	-29.35M	-27.08M	-12.33M	-8.33M	-6.18M	16.40M	30.41M	-2.31M	9.21M	8.76M
Leverage & Debt
Debt to Equity	-1.04	-2.24	-2.94	-2.11	-1.69	-2.14	-2.42	3.40	1.09	1.34	0.97	0.68
Debt Ratio	28.78	1.81	1.52	1.89	2.44	1.88	1.70	0.46	0.35	0.57	0.49	0.40
Efficiency & Turnover
Asset Turnover TTM	0.13	0.04	0.03	0.01	0.01	0.33	0.56	0.45	0.48	0.43	0.43	0.46
Days Sales Outstanding TTM	22.57	47.10	67.82	7,449.38	12,489.54	297.20	152.41	236.98	260.53	246.53	218.36	158.71
Receivables Turnover TTM	16.17	7.75	5.38	0.05	0.03	1.23	2.39	1.54	1.40	1.48	1.67	2.30
Per Share Metrics
Diluted EPS TTM	11.64	6.13	6.01	13.76	19.08	19.48	19.62	11.46	5.93	6.25	9.94	-
Free Cash Flow Per Share TTM	-4.12	-3.34	-3.23	-3.93	-5.84	-10.87	-13.54	-15.93	-14.88	-11.06	-12.37	-13.56
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-86.28%	-97.66%	-101.06%	-660.87%	-1,080.19%	37.77%	55.80%	73.72%	85.75%	37.84%	9.26%	-9.98%
Operating Profit Margin TTM	3,842.32%	3,087.43%	3,345.92%	8,122.87%	10,120.00%	337.22%	208.02%	89.46%	28.06%	51.47%	74.82%	61.46%
Net Profit Margin TTM	4,735.56%	3,215.57%	3,529.76%	8,630.62%	10,445.47%	399.92%	249.38%	102.57%	41.33%	54.00%	82.04%	67.00%
Growth Metrics
Net Revenue Growth (1Y)	95.28%	-93.85%	-97.06%	-98.21%	-98.53%	-50.23%	-25.18%	-9.48%	1.47%	0.64%	35.16%	130.52%
Net Income Growth (1Y)	-11.47%	-50.57%	-58.36%	50.43%	271.82%	268.57%	127.46%	38.57%	-17.55%	-73.11%	-51.90%	-68.27%
EPS Growth (1Y)	-39.01%	-68.53%	-69.35%	20.05%	221.69%	211.87%	97.38%	28.75%	-20.26%	-74.31%	-52.79%	-68.80%
Valuation Metrics
P/E TTM	0.16	0.73	1.00	0.60	0.26	0.32	0.71	1.03	3.29	2.27	2.43	3.90
P/B TTM	-0.21	-0.88	-1.48	-0.98	-0.69	-1.21	-3.12	3.13	1.68	1.19	1.89	2.46
P/S TTM	7.69	23.39	35.22	51.55	27.40	1.27	1.77	1.06	1.36	1.23	2.00	2.61
Market Cap	7.96M	21.03M	23.32M	27.27M	14.52M	18.61M	39.76M	31.24M	48.94M	36.07M	60.07M	85.37M
Enterprise Value	27.85M	33.18M	31.72M	50.58M	36.65M	39.95M	59.79M	46.00M	61.63M	38.26M	77.32M	95.20M
Calculated Values
Free Cash Flow TTM	-17.34M	-15.74M	-12.54M	-13.05M	-16.93M	-32.64M	-38.73M	-42.17M	-37.34M	-28.10M	-30.70M	-33.35M
Net Debt	19.89M	12.15M	8.40M	23.31M	22.12M	21.33M	20.03M	14.76M	12.69M	2.19M	17.25M	9.83M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-06-24Purchase

Owner: Safier, Jacob

Title: -

Shares: 10,000

Price/Share: $0.58

Value: $5,800.00

Shares Owned: 3,120,100

Relationship: TenPercentOwner

Ownership: Indirect

2024-06-24Sale

Owner: Safier, Jacob

Title: -

Shares: 10,000

Price/Share: $0.58

Value: $5,800.00

Shares Owned: 3,110,100

Relationship: TenPercentOwner

Ownership: Indirect

2024-02-01Purchase

Owner: Safier, Jacob

Title: -

Shares: 10,100

Price/Share: $0.33

Value: $3,333.00

Shares Owned: 3,110,100

Relationship: TenPercentOwner

Ownership: Indirect

2024-01-31Purchase

Owner: Safier, Jacob

Title: -

Shares: 5,000

Price/Share: $0.35

Value: $1,750.00

Shares Owned: 3,100,000

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-06-24	Safier, Jacob	TenPercentOwner	-	Indirect	Purchase	10,000	0.58	$5,800.00	3,120,100	4
2024-06-24	Safier, Jacob	TenPercentOwner	-	Indirect	Sale	10,000	0.58	$5,800.00	3,110,100	4
2024-02-01	Safier, Jacob	TenPercentOwner	-	Indirect	Purchase	10,100	0.33	$3,333.00	3,110,100	4
2024-01-31	Safier, Jacob	TenPercentOwner	-	Indirect	Purchase	5,000	0.35	$1,750.00	3,100,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-03-31

1.20%

Inst. Shares: 50,623

Shares Outstanding: 4,210,839

2024-12-31

1.44%

Inst. Shares: 60,623

Shares Outstanding: 4,210,839

2024-09-30

3.21%

Inst. Shares: 151,430

Shares Outstanding: 4,715,229

2024-06-30

3.84%

Inst. Shares: 149,105

Shares Outstanding: 3,886,073

2024-03-31

4.50%

Inst. Shares: 149,238

Shares Outstanding: 3,317,666

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-03-31	50,623	4,210,839	1.20%
2024-12-31	60,623	4,210,839	1.44%
2024-09-30	151,430	4,715,229	3.21%
2024-06-30	149,105	3,886,073	3.84%
2024-03-31	149,238	3,317,666	4.50%
2023-12-31	147,626	2,900,787	5.09%
2023-09-30	148,586	3,002,259	4.95%
2023-06-30	210,394	2,860,360	7.36%
2023-03-31	193,735	2,647,711	7.32%
2022-12-31	124,367	2,509,628	4.96%
2022-09-30	160,670	2,540,391	6.32%
2022-06-30	160,359	2,482,076	6.46%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Orgenesis Inc. (ORGS) — SEC Financial Statements & Analysis

Orgenesis Inc. (ORGS) is a pharmaceutical preparations company, incorporated in NV. Orgenesis Inc. trades on None as: ORGS. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), Orgenesis Inc. reported a 95.28% year-over-year revenue growth, a Gross Profit Margin of -86.28% (TTM), a Debt-to-Equity ratio of -1.04x, a Price-to-Sales (P/S) ratio of 7.69x (TTM), a Price-to-Book (P/B) ratio of -0.21x (TTM), at a market cap of $7.96M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 95.28%
Gross Profit Margin TTM: -86.28%
Debt To Equity: -1.04x
P/S TTM: 7.69x
P/B TTM: -0.21x
Market Cap: $7.96M

Data as of 2024-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Orgenesis Inc. in?

Orgenesis Inc. (ORGS) operates in the Pharmaceutical Preparations industry.

What is ORGS's market cap?

Orgenesis Inc. (ORGS) has a market capitalization of $7.96M as of 2024-12-31.

What is ORGS's P/E ratio?

Orgenesis Inc. (ORGS)'s trailing twelve month P/E ratio is 0.16x as of 2024-12-31.

What exchange does ORGS trade on?

Orgenesis Inc. (ORGS) trades on the None.

Where is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in NV.

Orgenesis Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Orgenesis Inc. (ORGS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Orgenesis Inc. (ORGS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.